April 30, 2016 6:54 PM ET


Company Overview of Inimex Pharmaceuticals Inc.

Company Overview

Inimex Pharmaceuticals Inc., a biopharmaceutical company, engages in the development and commercialization of innate defense regulators (IDRs) that modulate the body's innate defenses without causing inflammation. The company offers IMX942, an IDR product that improves survival, ameliorate tissue damage, and reduce bacterial infections through modulation of innate defenses. Its products are used to treat infections and conditions involving tissue injury; ventilator associated pneumonia, tracheobronchitis, bacteremia, endocarditis, and mucositis; and cancer diseases. Inimex Pharmaceuticals Inc. was founded in 2001 and is headquartered in Coquitlam, Canada.

3650 Wesbrook Mall

RPO Clarke Road

PO Box 64036

Coquitlam, BC V3J 7V6


Founded in 2001





Key Executives for Inimex Pharmaceuticals Inc.

Chief Executive Officer, President and Director
Age: 59
Co-Founder and Chairman of Scientific Advisory Board
Chief Financial Officer
Director of Target Discovery and Validation
Vice President of Product Development
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Plexagen Diagnostics Ltd. Americas
Capital 21 Holdings Inc. Americas
Alpha Cancer Technologies Inc. Americas
Northern Biologics Inc. Americas
LifeLike BioTissue Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Inimex Pharmaceuticals Inc., please visit www.inimexpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.